Monday - April 20, 2026
New Antibody-drug Conjugate Shows Clinical Benefit for Advanced Platinum-resistant Ovarian Cancer
April 19, 2026
PHILADELPHIA, Pennsylvania, April 19 [Category: Medical] -- The American Association for Cancer Research posted the following news release:

* * *

New Antibody-drug Conjugate Shows Clinical Benefit for Advanced Platinum-resistant Ovarian Cancer

*

The investigational drug led to objective response and disease control in patients with late-stage disease

SAN DIEGO - Patients with advanced platinum-resistant ovarian cancer whose diseas . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products